Women-Only Trial Supports Self-Expanding TAVR as the Way to Go

(MedPage Today) -- Transcatheter aortic valve replacement (TAVR) with a self-expanding valve still worked out better, at least in terms of hemodynamics, in the first head-to-head device trial exclusively in women. Among older women with symptomatic...
Source
MedPage Today
Opens original article in a new tab



